Fmr LLC Has $235.27 Million Stake in Option Care Health, Inc. (NASDAQ:OPCH)

Fmr LLC increased its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 134.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,516,448 shares of the company’s stock after purchasing an additional 4,304,896 shares during the period. Fmr LLC’s holdings in Option Care Health were worth $235,265,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. UMB Bank n.a. increased its position in Option Care Health by 937.5% during the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after buying an additional 750 shares during the period. GAMMA Investing LLC grew its stake in shares of Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after acquiring an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. increased its position in Option Care Health by 3,362.8% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after acquiring an additional 1,446 shares during the period. International Assets Investment Management LLC raised its stake in Option Care Health by 3,029.7% in the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock worth $91,000 after purchasing an additional 2,757 shares in the last quarter. Finally, Blue Trust Inc. boosted its holdings in Option Care Health by 14.8% in the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after purchasing an additional 377 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The shares were bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the acquisition, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $23.80 on Monday. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $34.63. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The stock’s 50-day simple moving average is $26.84 and its 200 day simple moving average is $28.87. The firm has a market capitalization of $4.05 billion, a PE ratio of 20.00, a price-to-earnings-growth ratio of 2.46 and a beta of 1.32.

Analyst Ratings Changes

Several brokerages have recently commented on OPCH. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and lowered their target price for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. JMP Securities lifted their price objective on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a report on Monday, September 30th. Barrington Research reduced their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a report on Thursday, October 31st. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Finally, Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and cut their price objective for the stock from $43.00 to $29.00 in a research report on Wednesday, October 30th. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $30.83.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.